| 000 | 03812naa a22005297i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-053 | ||
| 003 | local | ||
| 005 | 20261005174905.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2022 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.3343/alm.2022.42.1.3 _2doi |
|
| 035 | _a(local)EuropePMC:PMC8368230 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aKhaldoun Ghazal _eauthor. |
|
| 245 | 1 | 0 |
_aHormone Immunoassay Interference: A 2021 Update. / _cKhaldoun Ghazal; Severine Brabant; Dominique Prie [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bKorean Society for Laboratory Medicine, _c2022. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aImmunoassays are powerful qualitative and quantitative analytical techniques. Since the first description of an immunoassay method in 1959, advances have been made in assay designs and analytical characteristics, opening the door for their widespread implementation in clinical laboratories. Clinical endocrinology is closely linked to laboratory medicine because hormone quantification is important for the diagnosis, treatment, and prognosis of endocrine disorders. Several interferences in immunoassays have been identified through the years; although some are no longer encountered in daily practice, cross-reaction, heterophile antibodies, biotin, and anti-analyte antibodies still cause problems. Newer interferences are also emerging with the development of new therapies. The interfering substance may be exogenous (e.g., a drug or substance absorbed by the patient) or endogenous (e.g., antibodies produced by the patient), and the bias caused by interference can be positive or negative. The consequences of interference can be deleterious when clinicians consider erroneous results to establish a diagnosis, leading to unnecessary explorations or inappropriate treatments. Clinical laboratories and manufacturers continue to investigate methods for the detection, elimination, and prevention of interferences. However, no system is completely devoid of such incidents. In this review, we focus on the analytical interferences encountered in daily practice and possible solutions for their detection or elimination. | |
| 540 |
_aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by-nc/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aImmunoassay | |
| 650 | 4 | _aHormone | |
| 650 | 4 | _ainterference | |
| 650 | 4 | _abiotin | |
| 650 | 4 | _aHeterophile Antibodies | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aimmunoassay | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aSeverine Brabant _eauthor. |
|
| 700 | 0 |
_aDominique Prie _eauthor. |
|
| 700 | 0 |
_aMarie-Liesse Piketty _eauthor. |
|
| 773 | 0 |
_tAnnals of laboratory medicine _gVol. 42, no. 1, (2022), pages/article 3-23 _x2234-3806 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC8368230 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC8368230 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1195 _d1195 |
||